Anhui Fengyuan Pharmaceutical Co., Ltd. (000153.SZ)
000153.SZ Stock Price Chart
Explore Anhui Fengyuan Pharmaceutical Co., Ltd. interactive price chart. Choose custom timeframes to analyze 000153.SZ price movements and trends.
000153.SZ Company Profile
Discover essential business fundamentals and corporate details for Anhui Fengyuan Pharmaceutical Co., Ltd. (000153.SZ) to support your stock research and investment decisions.
Sector
Healthcare
Industry
Drug Manufacturers - Specialty & Generic
IPO Date
20 Sept 2000
Employees
4.54K
Website
https://www.bbcayy.comCEO
Tianle Ru
Description
Anhui Fengyuan Pharmaceutical Co., Ltd. researches and develops, produces, and sells biological pharmacy, chemical pharmacy, and traditional Chinese medicines primarily in China. It offers antipyretic-analgesic, cardiovascular, antibiotic, nervous system, anti-tumor, antiulcer, and hormone drugs, as well as nutraceuticals. The company also provides general medicines for vitamin and mineral deficiency; medicines for resisting parasitic diseases and microorganisms; coenzymes; and antiviral and uterine contractive medicines. In addition, it offers sedative-hypnotic drugs; drugs for curing mesenteric stress syndrome; drugs for lowering blood pressure; and drugs for curing benign prostatic hyperplasia. The company also exports its products to Europe, North America, Africa, Southeast Asia, and Central Asia. Anhui Fengyuan Pharmaceutical Co., Ltd. was founded in 1997 and is based in Hefei, China.
000153.SZ Financial Timeline
Browse a chronological timeline of Anhui Fengyuan Pharmaceutical Co., Ltd. corporate events including earnings releases, dividend announcements, and stock splits.
Dividend declared on 30 May 2025
A dividend of ¥0.10 per share was announced, adjusted to ¥0.10. The dividend was paid on 30 May 2025.
Earnings released on 22 May 2025
Earnings released on 22 May 2025
EPS came in at ¥0.03 , while revenue for the quarter reached ¥1.02B .
Earnings released on 31 Mar 2025
EPS came in at ¥0.08 , while revenue for the quarter reached ¥940.76M .
Earnings released on 30 Sept 2024
EPS came in at ¥0.10 , while revenue for the quarter reached ¥953.55M .
Earnings released on 30 Jun 2024
EPS came in at ¥0.11 , while revenue for the quarter reached ¥1.19B .
Dividend declared on 7 Jun 2024
A dividend of ¥0.15 per share was announced, adjusted to ¥0.15. The dividend was paid on 7 Jun 2024.
Stock split effective on 7 Jun 2024
Shares were split 7 : 5 , changing the number of shares outstanding and the price per share accordingly.
Earnings released on 22 May 2024
EPS came in at ¥0.14 , while revenue for the quarter reached ¥1.12B .
Earnings released on 22 Feb 2024
EPS came in at ¥0.12 , while revenue for the quarter reached ¥938.65M .
Earnings released on 31 Dec 2023
EPS came in at ¥0.05 , while revenue for the quarter reached ¥1.05B .
Earnings released on 30 Jun 2023
EPS came in at ¥0.17 , while revenue for the quarter reached ¥1.08B .
Dividend declared on 16 Jun 2023
A dividend of ¥0.10 per share was announced, adjusted to ¥0.07. The dividend was paid on 16 Jun 2023.
Earnings released on 31 Mar 2023
EPS came in at ¥0.14 , while revenue for the quarter reached ¥1.21B .
Earnings released on 1 Jan 2023
EPS came in at ¥0.06 , while revenue for the quarter reached ¥1.14B .
Earnings released on 30 Sept 2022
EPS came in at ¥0.12 , while revenue for the quarter reached ¥967.90M .
Dividend declared on 5 Jul 2022
A dividend of ¥0.10 per share was announced, adjusted to ¥0.07. The dividend was paid on 5 Jul 2022.
Earnings released on 30 Jun 2022
EPS came in at ¥0.17 , while revenue for the quarter reached ¥934.94M .
Earnings released on 31 Mar 2022
EPS came in at ¥0.12 , while revenue for the quarter reached ¥962.64M .
Earnings released on 31 Dec 2021
EPS came in at ¥0.08 , while revenue for the quarter reached ¥882.09M .
Earnings released on 30 Sept 2021
EPS came in at ¥0.09 , while revenue for the quarter reached ¥876.17M .
Earnings released on 30 Jun 2021
EPS came in at ¥0.12 , while revenue for the quarter reached ¥879.53M .
Earnings released on 23 Apr 2021
EPS came in at ¥0.11 , while revenue for the quarter reached ¥894.91M .
Earnings released on 31 Mar 2021
EPS came in at ¥0.09 , while revenue for the quarter reached ¥863.88M .
Earnings released on 30 Sept 2020
EPS came in at ¥0.04 , while revenue for the quarter reached ¥848.51M .
000153.SZ Stock Performance
Access detailed 000153.SZ performance analysis with candlestick charts, real‑time intraday data and historical financial metrics for comprehensive insights.
Explore Related Stocks
Compare companies within the same sector by viewing performance, key financials, and market trends. Select a symbol to access the full profile.